Curebase’s Enhanced Telemedicine Feature Expands Patient Access to Edesa Biotech Derm Study

SAN FRANCISCO: SAN FRANCISCO, Nov. 30, 2021 /PRNewswire/ -- Curebase, a company committed to democratizing access to clinical studies, today announced that a newly released telemedicine feature of its decentralized clinical trial (DCT) platform has expanded patient access for its client Edesa Biotech, Inc., a clinical-stage biopharmaceutical company focused on...

Click to view original post